These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6242259)

  • 21. Thalassemia.
    Brown EB
    Prog Clin Biol Res; 1983; 127():33-42. PubMed ID: 6889403
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrocardiographic and radiologic evaluation in cardiac involvement in patients with beta-thalassemia major].
    Lo Jacono F; Agnello D; Malizia R; Maltese I; Marasa' R
    Pediatria (Napoli); 1980 Sep; 88(3):385-93. PubMed ID: 7220158
    [No Abstract]   [Full Text] [Related]  

  • 23. The management of thalassemia major.
    Pearson HA; O'Brien RT
    Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
    [No Abstract]   [Full Text] [Related]  

  • 24. Improved oxygen delivery to tissues and iron chelator transport through the use of lysed and resealed red blood cells: a new perspective on Cooley's anemia therapy.
    Ropars C; Teisseire B; Avenard G; Chassaigne M; Hurel C; Girot R; Nicolau C
    Ann N Y Acad Sci; 1985; 445():304-15. PubMed ID: 3860134
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.
    Wolfe L; Olivieri N; Sallan D; Colan S; Rose V; Propper R; Freedman MH; Nathan DG
    N Engl J Med; 1985 Jun; 312(25):1600-3. PubMed ID: 4000198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.
    Vaskaridou E; Konstantopoulos K; Kyriakou D; Loukopoulos D
    Haematologica; 1993; 78(3):183-4. PubMed ID: 8375749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of the improved prognosis in thalassemia major.
    Modell B
    Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
    [No Abstract]   [Full Text] [Related]  

  • 28. Iron chelating therapy in thalassemia: current problems.
    Russo G
    Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
    De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
    Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies on iron chelation in patients with thalassemia major.
    Freedman MH; Olivieri N; Benson L; Liu P; McClelland R; St Louis P; Templeton D; Koren G
    Haematologica; 1990; 75 Suppl 5():74-83. PubMed ID: 2086384
    [No Abstract]   [Full Text] [Related]  

  • 32. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
    Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.
    Kattamis C; Lagos P; Langona E
    Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of cardiac function in patients with thalassemia major.
    Nienhuis AW; Griffith P; Strawczynski H; Henry W; Borer J; Leon M; Anderson WF
    Ann N Y Acad Sci; 1980; 344():384-96. PubMed ID: 6930878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertransfusion, chelating and immunocorrective therapy in beta-thalassemia major].
    Zeĭnalova AA; Ragimov AA; Dashkova NG; Mamedova FR; Kurbanova SA
    Pediatriia; 1987; (2):55-60. PubMed ID: 3575062
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-thalassaemia--the Johannesburg experience.
    Poole JE; Cohn RJ; Roode H; Spector I
    S Afr Med J; 1989 Apr; 75(8):367-70. PubMed ID: 2652340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
    Delea TE; Edelsberg J; Sofrygin O; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Transfusion; 2007 Oct; 47(10):1919-29. PubMed ID: 17880620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of thalassemias].
    Bender-Götze C
    Monatsschr Kinderheilkd (1902); 1979 Dec; 127(12):714-5. PubMed ID: 514281
    [No Abstract]   [Full Text] [Related]  

  • 39. Current therapy and new approaches to the treatment of thalassemia major.
    Wolfe L; Sallan D; Nathan DG
    Ann N Y Acad Sci; 1985; 445():248-55. PubMed ID: 3860127
    [No Abstract]   [Full Text] [Related]  

  • 40. A successful pregnancy outcome in transfusion dependent thalassaemia major.
    Meadows K
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):43-4. PubMed ID: 6588961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.